Our finding opened the possibility that the physical interplay between TBX3 and the Wnt pathway (Fig. 7) might underlie the oncogenic activity that had been associated to its aberrant expression in CRC and other cancers (32, 34, 68, 69). This evidence concerns the gene TBX3 and cancer.